Gabriela Garcia,Richard J. Johnson,Christopher J. Rivard,Miguel A. Lanaspa-Garcia
申请号：
US13521881
公开号：
US08697628B2
申请日:
2011.01.13
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides compounds and compositions that modulate adenosine monophosphate deaminase (AMPD) and methods for using the same to treat a clinical condition associated with the metabolic syndrome or a disease associated with the metabolic syndrome. In particular, the present invention provides a compound and a composition comprising a selective AMPD2 inhibitor and methods for using the same, for example, to treat a clinical condition associated with metabolic syndrome as well as diseases manifested by the metabolic syndrome.
